189 related articles for article (PubMed ID: 32353258)
1. Replication Stress Induces ATR/CHK1-Dependent Nonrandom Segregation of Damaged Chromosomes.
Xing M; Zhang F; Liao H; Chen S; Che L; Wang X; Bao Z; Ji F; Chen G; Zhang H; Li W; Chen Z; Liu Y; Hickson ID; Shen H; Ying S
Mol Cell; 2020 May; 78(4):714-724.e5. PubMed ID: 32353258
[TBL] [Abstract][Full Text] [Related]
2. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
3. An extending ATR-CHK1 circuitry: the replication stress response and beyond.
Simoneau A; Zou L
Curr Opin Genet Dev; 2021 Dec; 71():92-98. PubMed ID: 34329853
[TBL] [Abstract][Full Text] [Related]
4. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage.
Gupta D; Lin B; Cowan A; Heinen CD
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1523-1528. PubMed ID: 29378956
[TBL] [Abstract][Full Text] [Related]
5. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.
Edwards TG; Bloom DC; Fisher C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259
[TBL] [Abstract][Full Text] [Related]
6. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Ghelli Luserna Di Rorà A; Ghetti M; Ledda L; Ferrari A; Bocconcelli M; Padella A; Napolitano R; Fontana MC; Liverani C; Imbrogno E; Bochicchio MT; Paganelli M; Robustelli V; Sanogo S; Cerchione C; Fumagalli M; Rondoni M; Imovilli A; Musuraca G; Martinelli G; Simonetti G
Cell Biol Toxicol; 2023 Jun; 39(3):795-811. PubMed ID: 34519926
[TBL] [Abstract][Full Text] [Related]
7. A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation.
Kabeche L; Nguyen HD; Buisson R; Zou L
Science; 2018 Jan; 359(6371):108-114. PubMed ID: 29170278
[TBL] [Abstract][Full Text] [Related]
8. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
[TBL] [Abstract][Full Text] [Related]
9. Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer.
Guo Y; Wang J; Benedict B; Yang C; van Gemert F; Ma X; Gao D; Wang H; Zhang S; Lieftink C; Beijersbergen RL; Te Riele H; Qiao X; Gao Q; Sun C; Qin W; Bernards R; Wang C
Genome Med; 2021 Oct; 13(1):166. PubMed ID: 34663432
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
Massey AJ
Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
[TBL] [Abstract][Full Text] [Related]
11. Critical role of SMG7 in activation of the ATR-CHK1 axis in response to genotoxic stress.
Ho K; Luo H; Zhu W; Tang Y
Sci Rep; 2021 Apr; 11(1):7502. PubMed ID: 33820915
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Chk1 kinase activity dynamics in live single cell imaging assays.
Lebrec V; Gavet O
Methods Cell Biol; 2024; 182():221-236. PubMed ID: 38359979
[TBL] [Abstract][Full Text] [Related]
13. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.
Moiseeva TN; Yin Y; Calderon MJ; Qian C; Schamus-Haynes S; Sugitani N; Osmanbeyoglu HU; Rothenberg E; Watkins SC; Bakkenist CJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13374-13383. PubMed ID: 31209037
[TBL] [Abstract][Full Text] [Related]
14. Dormant origin signaling during unperturbed replication.
Moiseeva TN; Bakkenist CJ
DNA Repair (Amst); 2019 Sep; 81():102655. PubMed ID: 31311769
[TBL] [Abstract][Full Text] [Related]
15. Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome.
Lebrec V; Poteau M; Morretton JP; Gavet O
Dev Cell; 2022 Mar; 57(5):638-653.e5. PubMed ID: 35245445
[TBL] [Abstract][Full Text] [Related]
16. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets.
Khamidullina AI; Abramenko YE; Bruter AV; Tatarskiy VV
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279263
[TBL] [Abstract][Full Text] [Related]
17. Claspin - checkpoint adaptor and DNA replication factor.
Smits VAJ; Cabrera E; Freire R; Gillespie DA
FEBS J; 2019 Feb; 286(3):441-455. PubMed ID: 29931808
[TBL] [Abstract][Full Text] [Related]
18. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
[TBL] [Abstract][Full Text] [Related]
19. Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions.
Michelena J; Gatti M; Teloni F; Imhof R; Altmeyer M
J Cell Biol; 2019 Sep; 218(9):2865-2875. PubMed ID: 31366665
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.
Sanjiv K; Hagenkort A; Calderón-Montaño JM; Koolmeister T; Reaper PM; Mortusewicz O; Jacques SA; Kuiper RV; Schultz N; Scobie M; Charlton PA; Pollard JR; Berglund UW; Altun M; Helleday T
Cell Rep; 2016 Jan; 14(2):298-309. PubMed ID: 26748709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]